Total Payments
$11,350
2024 Payments
$1,076
Companies
47
Transactions
441
Medicare Patients
5,490
Medicare Billing
$394,958
Payment Breakdown by Category
Food & Beverage$11,039 (97.3%)
Other$235.31 (2.1%)
Education$75.30 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,039 | 429 | 97.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $235.31 | 2 | 2.1% |
| Education | $75.30 | 10 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,045 | 49 | $0 (2024) |
| Abbott Laboratories | $976.77 | 22 | $0 (2024) |
| Amgen Inc. | $863.85 | 37 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $779.11 | 50 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $764.35 | 43 | $0 (2024) |
| Boston Scientific Corporation | $762.22 | 20 | $0 (2024) |
| Chiesi USA, Inc. | $492.92 | 13 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $483.97 | 28 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $463.72 | 20 | $0 (2024) |
| Amarin Pharma Inc. | $412.72 | 13 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,076 | 33 | Abbott Laboratories ($211.77) |
| 2023 | $1,385 | 34 | E.R. Squibb & Sons, L.L.C. ($224.77) |
| 2022 | $979.24 | 32 | Abbott Laboratories ($194.44) |
| 2021 | $850.38 | 28 | AstraZeneca Pharmaceuticals LP ($292.25) |
| 2020 | $219.47 | 8 | PFIZER INC. ($122.58) |
| 2019 | $1,412 | 62 | Amarin Pharma Inc. ($254.40) |
| 2018 | $2,696 | 120 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($314.50) |
| 2017 | $2,732 | 124 | Boehringer Ingelheim Pharmaceuticals, Inc. ($303.74) |
All Payment Transactions
441 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: DIABETES | ||||||
| 12/11/2024 | Abbott Laboratories | CONFIRM RX (Device) | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: Cardiac Rhythm Management | ||||||
| 12/10/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $32.26 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/06/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $28.23 | General |
| Category: Heart Failure | ||||||
| 11/12/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $8.86 | General |
| Category: Cardiovascular | ||||||
| 11/12/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $8.54 | General |
| Category: Cardiovascular | ||||||
| 09/25/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $23.53 | General |
| Category: Cardiology | ||||||
| 08/29/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $17.53 | General |
| Category: Cardiovascular | ||||||
| 08/19/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $13.11 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/30/2024 | Abbott Laboratories | ASSURITY (Device) | Food and Beverage | In-kind items and services | $22.89 | General |
| Category: Cardiac Rhythm Management | ||||||
| 07/29/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.14 | General |
| Category: DIABETES | ||||||
| 07/22/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/08/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: Cardiology | ||||||
| 06/26/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/24/2024 | Abbott Laboratories | CONFIRM RX (Device) | Food and Beverage | In-kind items and services | $113.69 | General |
| Category: Cardiac Rhythm Management | ||||||
| 06/03/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $15.54 | General |
| Category: Not Applicable | ||||||
| 05/30/2024 | Medtronic, Inc. | MVP (Device) | Food and Beverage | In-kind items and services | $52.66 | General |
| Category: Vascular Embolization | ||||||
| 05/16/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $109.32 | General |
| Category: Cardiovascular | ||||||
| 04/22/2024 | BIOTRONIK INC. | Orsiro Mission (Device) | Food and Beverage | In-kind items and services | $116.05 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/11/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/08/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.45 | General |
| Category: DIABETES | ||||||
| 04/04/2024 | ShockWave Medical, Inc | Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter (Device) | Food and Beverage | In-kind items and services | $30.30 | General |
| Category: Lithoplasty | ||||||
| 03/27/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: DIABETES | ||||||
| 03/26/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $23.87 | General |
| Category: Cardiovascular | ||||||
| 03/08/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $30.29 | General |
| Category: WATCHMAN FLX_IC | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 1,364 | 1,570 | $404,258 | $89,211 |
| 2022 | 19 | 1,450 | 1,724 | $468,844 | $107,040 |
| 2021 | 24 | 1,431 | 1,652 | $446,419 | $112,714 |
| 2020 | 15 | 1,245 | 1,432 | $394,428 | $85,993 |
Total Patients
5,490
Total Services
6,378
Medicare Billing
$394,958
Procedure Codes
85
All Medicare Procedures & Services
85 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 415 | 547 | $92,990 | $45,602 | 49.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 73 | 73 | $79,570 | $9,628 | 12.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 131 | 133 | $59,850 | $6,903 | 11.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 45 | 61 | $12,200 | $5,543 | 45.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 335 | 362 | $31,494 | $3,535 | 11.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 33 | 33 | $8,910 | $3,527 | 39.6% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 15 | 15 | $36,225 | $2,558 | 7.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 17 | 17 | $5,440 | $2,188 | 40.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 22 | 22 | $5,940 | $2,097 | 35.3% |
| Q9957 | Injection, perflutren lipid microspheres, per ml | Office | 2023 | 26 | 52 | $7,540 | $1,774 | 23.5% |
| 93308 | Ultrasound of heart, follow-up | Office | 2023 | 16 | 16 | $5,440 | $1,017 | 18.7% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 13 | 15 | $2,775 | $874.44 | 31.5% |
| 93350 | Ultrasound of heart during rest, exercise and/or drug-induced stress with report | Facility | 2023 | 14 | 14 | $4,970 | $739.76 | 14.9% |
| 99451 | Telephone, internet, or electronic health record assessment and management with written report by consulting physician, at least 5 minutes | Office | 2023 | 23 | 24 | $960.00 | $653.28 | 68.1% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2023 | 31 | 31 | $22,010 | $558.83 | 2.5% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 13 | 13 | $5,629 | $507.26 | 9.0% |
| 93227 | Electrocardiogram (ecg) 2-day continuous with review by health care professional | Office | 2023 | 35 | 35 | $6,475 | $366.57 | 5.7% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 22 | 22 | $3,300 | $359.26 | 10.9% |
| 93225 | Electrocardiogram (ecg) 2-day continuous | Office | 2023 | 35 | 35 | $5,530 | $318.52 | 5.8% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 22 | 22 | $3,300 | $236.72 | 7.2% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Facility | 2023 | 14 | 14 | $2,310 | $191.52 | 8.3% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 14 | 14 | $1,400 | $33.60 | 2.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 440 | 596 | $101,320 | $51,391 | 50.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 86 | 86 | $93,740 | $11,101 | 11.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 66 | 66 | $17,820 | $6,932 | 38.9% |
About Dr. Bruce Schilt, MD
Dr. Bruce Schilt, MD is a Interventional Cardiology healthcare provider based in Noblesville, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/15/2005. The National Provider Identifier (NPI) number assigned to this provider is 1154320893.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bruce Schilt, MD has received a total of $11,350 in payments from pharmaceutical and medical device companies, with $1,076 received in 2024. These payments were reported across 441 transactions from 47 companies. The most common payment nature is "Food and Beverage" ($11,039).
As a Medicare-enrolled provider, Schilt has provided services to 5,490 Medicare beneficiaries, totaling 6,378 services with total Medicare billing of $394,958. Data is available for 4 years (2020–2023), covering 85 distinct procedure/service records.
Ad
Practice Information
- Specialty Interventional Cardiology
- Other Specialties Cardiovascular Disease, Critical Care Medicine
- Location Noblesville, IN
- Active Since 07/15/2005
- Last Updated 08/15/2022
- Taxonomy Code 207RI0011X
- Entity Type Individual
- NPI Number 1154320893
Products in Payments
- ELIQUIS (Drug) $707.26
- ENTRESTO (Drug) $680.48
- BRILINTA (Drug) $608.01
- Repatha (Biological) $583.71
- WATCHMAN (Device) $581.81
- XARELTO (Drug) $483.97
- Vascepa (Drug) $412.72
- LifeVest (Device) $374.34
- JARDIANCE (Drug) $350.43
- CLEVIPREX (Drug) $290.21
- CAMZYOS (Drug) $263.43
- ZONTIVITY (Drug) $261.77
- Corlanor (Drug) $254.09
- FARXIGA (Drug) $248.18
- PRALUENT (Drug) $242.25
- Orsiro Mission (Device) $230.48
- ORENITRAM (Drug) $221.83
- SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER (Device) $206.33
- KENGREAL (Drug) $202.71
- Confirm Rx (Device) $175.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.